Showing results (61-70 of 157) with videos related to
Sort By:
Pageof 16
Plos One|April 27, 2019
Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic reviewLaura S M Kuula, Kati M Viljemaa, Janne T Backman, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectivelyXia Wen, Jun-Sheng Wang, Janne T Backman, et al.Clinical Pharmacology and Therapeutics|July 5, 2003
Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinideMikko Niemi, Mikko Neuvonen, Laura Juntti-Patinen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomesJun-Sheng Wang, Mikko Neuvonen, Xia Wen, et al.Journal of Clinical Pharmacology|April 20, 2010
Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskirenTuija Tapaninen, Janne T Backman, Kaisa J Kurkinen, et al.Basic & Clinical Pharmacology & Toxicology|July 7, 2005
Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8Aleksi Tornio, Marja K Pasanen, Jouko Laitila, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2012
Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and responseAnne M Filppula, Mikko Neuvonen, Jouko Laitila, et al.Basic & Clinical Pharmacology & Toxicology|June 27, 2015
Drug-Related Inadvertent Deaths in a University Hospital--A Declining TrendOuti Lapatto-Reiniluoto, Laura Patinen, Mikko Niemi, et al.British Journal of Clinical Pharmacology|August 29, 2006
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjectsJanne T Backman, Marjo J Karjalainen, Mikko Neuvonen, et al.British Journal of Clinical Pharmacology|March 18, 2004
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjectsMikko Niemi, Lauri I Kajosaari, Mikko Neuvonen, et al.Pageof 16